2024-514488-24-02尚未招募2 期
(CIAO@TBI) Complement Inhibition: Attacking Overshooting Inflammation @fter traumatic brain injury
Leids Universitair Medisch Centrum (LUMC)3 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2024年10月8日最近更新:
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 106
- 试验地点
- 3
- 主要终点
- Therapy Intensity Level Scale
研究概览
简要总结
To study the safety and efficacy of C1-INH in patients with traumatic brain injury
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- •Traumatic Brain Injury
- •Age > 18 years
- •ICP monitor
排除标准
- 未提供
结局指标
主要结局
Therapy Intensity Level Scale
Therapy Intensity Level Scale
次要结局
- Serious Adverse Events (SAE)
- Glasgow Outcome Scale Extended
研究者
Inge van Erp
Scientific
Leids Universitair Medisch Centrum (LUMC)
研究点 (3)
Loading locations...
相似试验
招募中
2 期
Complement Inhibition: Attacking the Overshooting Inflammation @fter Traumatic Brain Injury ( A phase II trial on the safety and efficacy of C1 esterase inhibitor Cinryze for the acute management of severe traumatic brain injury)NL-OMON52831eids Universitair Medisch Centrum106
进行中（未招募）
1 期
C1-inhibitor for the acute management of subarachnoid hemorrhageSubarachnoid hemorrhageEUCTR2020-005731-67-NLHaaglanden Medisch Centrum128
尚未招募
2 期
Complement Inhibition: Attacking Overshooting inflammation @fter Subarachnoid Hemorrhage (CIAO@SAH trial)NL-OMON51205Haaglanden Medisch Centrum128
尚未招募
不适用
Identification of complement inhibitors and complement regulatory proteins in ABO-incompatible compare with HLA-incompatible kidney transplantatioABOi kidney transplantationHLAi kidney transplantationAccommodationABO incompatibility or ABO incompatible kidney transplantationComplement regulatory proteinsComplement inhibitorsHLA incompatibility or HLA incompatible kidney transplantationKidney transplantationTCTR20210904002/A30
招募中
2 期
Randomized, controlled study of inflammation inhibition in the treatment of pneumonia by the SARS-Cov-2 virusCOMPVID STUDYPneumonia by the SARS-CoV-2 virusU.07.1RBR-88bjcvHospital Eduardo de Menezes